Objectives: To assess quality of measurements of mean arterial pressure (MAP), mean uterine artery pulsatility index (UtPI), pregnancy-associated plasma protein A (PAPP-A) and placental growth factor (PlGF) in first trimester screening for pre-eclampsia program. Methods: Consecutive patients attending first trimester screening for aneuploidies in a large practice in Sydney, Australia, from May 2014 to February 2017 also had combined screening for pre-eclampsia based on the Fetal Medicine Foundation (FMF) algorithm. Distributions of MAP, UtPI, PAPP-A and PlGF, expressed as multiples of the median (MoM) were plotted in relation to the previously published UK median. Temporal analyses were produced by cumulative sum charts (CUSUM) and monthly distributions. Central tendency and dispersion charts were also produced for each individual UtPI operator. Results: 26,543 women attended for first trimester assessment and 21,010 had screening for pre-eclampsia with all four markers measured. Median MAP (n=26,450) UtPI (n=25,672), 471) and PlGF (n=21,723) MoM were 0.959, 1.031, 1.137 and 0.977, respectively. Of those, MAP and PAPP-A measurements were outside the expected range (±0.2 SD Log 10 [MoM]), and PlGF had a negative bias after March 2016. Most sonographers (40/46) measured UtPI within the acceptable range. The screen positive rate (SPR) for preterm pre-eclampsia, using a cut-off of 1:100, was 11.8%, similar with previous validation studies. Conclusions: While slight variations on biomarkers could be due to population characteristics and are unlikely to have major consequences on detection rate, bigger biases might affect significantly the SPR. Therefore, quality assurance process is essential in a first trimester screening program. Objectives: Hypertensive disorders of pregnancy (HDP) are associated with impaired placentation, as evidenced by abnormal uterine artery (UtA) Doppler. UtA mean pulsatility index (PI) shows a progressive decline with gestational age (GA). However, previous studies have reported that a proportion of pregnancies demonstrate worsening of the UtA Doppler. The aim of this study was to investigate the incidence of HDP according to the change in the UtA mean PI between the second and third trimester. Methods: This cohort study included singleton pregnancies undergoing longitudinal UtA Doppler assessment in the second and third trimester. All the parameters were converted into centiles and multiples of the median (MoM) adjusting for GA. The study cohort was divided into 2 groups according to the change in the UtA Doppler between the second and third trimesters (decline or no change vs increase in the mean PI MoM). HDP included women who developed pre-eclampsia and gestational hypertension. Regression analysis was used to adjust for potential confounders. Results: The analysis included 5887 pregnancies. The incidence of HDP was significantly higher in the group with worsening of the UtA mean PI compared to those without (7.9% vs 5.8%; p<0.002). Logistic regression analysis demonstrated that both the second trimester UtA PI MoM (OR 8.12, 95% CI 5.07-13.00; p<0.001) and the difference between the 2 trimesters (OR 3.41, 95% CI 2.434-4.768; p<0.001) were significant independent predictors for the development of HDP.
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Echocardiography and heart rate variability in pregnant women with essential arterial hypertension and pre-eclampsia
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Objectives: Pre-eclampsia is associated with pregnancy in 2-8% of cases. Arterial hypertension presents danger for the mother and fetus and provokes pre-eclampsia.
Our research represents a comparative evaluation of echocardiography and heart rate variability (HRV) data of pregnant women with essential arterial hypertension, gravidas suffering from pre-eclampsia and healthy carriers. Methods: Three groups of pregnant women were examined: 11 had essential arterial hypertension (group 1, average age 35,3±1,0), 10 had pre-eclampsia (group 2, average age -30,1±1,7) and 5 were healthy (group 3, 33±1,7 age). An echocardiography and daily ECG-monitoring with HRV evaluation were conducted for all patients.
Results:
The study has revealed a statistically significant increase in the interventricular septum thickness in the group 1, when compared to the group 2 (p<0.05). At the same time left ventricle (LV) ejection fraction was significantly higher in the group 2 than in other groups (p<0.05). There was no difference in the end-diastolic size and LV myocardium masse index between the groups. Results showed a statistically significant decrease of standard deviation normal to normal beat (SDNN) (p<0,01), SDNNi (SDNN index) and SDANNi (p<0,05) in group 1 compared with group 3. A strong negative correlation was found between the age of patients in the group 1 and their SDNN (correlation coefficient -0,8) and rMSSD data values (correlation coefficient -0,85). All pregnant women with obesity in groups 1 and 2 had different grade of uterine-placental hemodynamics disorders (odds ratio -3,75). Conclusions: Carriers with pre-eclampsia have increased left ventricle ejection fraction, which is not accompanied with the decline of HRV measures. Pregnant women with essential arterial hypertension have deterioration of HRV measures. Obesity is associated with more frequent cases of uterine-placental hemodynamics disorders. In this study, we made a comprehensive evaluation of in vivo vascular function (including flow-mediated dilatation (FMD), peripheral arterial tonometry (PAT), and arterial stiffness) in pre-eclamptic patients and compared them to normal pregnancies. In addition, we assessed the evolution of vascular function during normal pregnancy and the trend in vascular function after pre-eclamptic pregnancies. Methods: 14 patients with pre-eclampsia (PE) and 14 healthy pregnant controls were included. Endothelial function was determined by FMD and PAT, arterial stiffness by carotid-femoral pulse wave velocity (cfPWV) and augmentation index (AIx). Results: The reactive hyperemia index (RHI) assessed using PAT is decreased at the third trimester in comparison to the first trimester in an uncomplicated pregnancy (1.5±0.3 vs 2.3±0.6, p=0.001). Arterial stiffness is significantly higher in PE versus normal pregnancy (cfPWV 7.7±0.9 vs 6.0±0.8; AIx 23±8.8 vs 9±9.8; p<0.001). Endothelial function obtained by FMD is deteriorated in PE versus normal pregnancy (4.8±3.1 vs 8.5±4.1; p=0.015), while endothelial function assessment by PAT is improved in PE versus normal pregnancy (2.1±0.4 vs 1.5±0.3; p=0.001). Both arterial stiffness (cfPWV 7.0±0.6 vs 7.9±0.9; p=0.009, AIx 6.9±11.0 vs 26.3±7.8; p<0.0001) and endothelial function obtained by FMD (9.0±3.9 vs 5.2±3.7; p=0.02) are ameliorated six months after PE. Objectives: The aim was to determine the predictive role of combined screening for late-onset gestational hypertension by fetal ultrasound measurements, third trimester uterine arteries (UtAs) Doppler imaging, and maternal history. Methods: This prospective study on singleton pregnancies was conducted at the tertiary centre of Maternal and Fetal Medicine of the University of Padua during the period between January 2012 and December 2014. Ultrasound examination (fetal biometry, fetal wellbeing, maternal Doppler study, fetal abdominal aorta intima-media thickness [aIMT] , and fetal kidney volumes), clinical data (mother age, pre-pregnancy body mass index [BMI] , and parity), and pregnancy outcomes were collected. The P value <0.05 was defined significant considering a 2-sided alternative hypothesis. The distribution normality of variables were assessed using Kolmogorov-Smirnoff test. Data were presented by mean (±standard deviation), median and interquartile range, or percentage and absolute values. We considered data from 1381 ultrasound examinations at 29 to 32 weeks gestation, and in 73 cases late gestational hypertension developed after 34 weeks' gestation. Results: The final multivariate model found that fetal aIMT as well as fetal umbilical artery pulsatility index (PI), maternal age, maternal pre-pregnancy BMI, parity, and mean PI of maternal UtAs, assessed at ultrasound examination of 29 to 32 weeks' gestation, were significant and independent predictors for the development of gestational hypertension after 34 weeks' gestation. The area under the curve of the model was 81.07% (95% confidence interval, 75.83%-86.32%). A nomogram was developed starting from multivariate logistic regression coefficients.
Conclusions: Late-gestational hypertension could be independently predicted by fetal aIMT assessment at 29 to 32 weeks' gestation, ultrasound Doppler waveforms, and maternal clinical parameters.
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Does the presence of ascites among women with severe pre-eclampsia correlate with the severity and poor maternal and neonatal outcomes? Objectives: The presence of ascites in patients with severe pre-eclampsia may impact fetal and maternal outcomes compared to patients with severe pre-eclampsia without ascites. The objectives of this study were to determine the prevalence of ascites in women with severe pre-eclampsia and whether the presence of ascites correlates with a higher risk of maternal and neonatal complications. Methods: A prospective cohort study of patients admitted with severe pre-eclampsia over a 7 month period at the University and Teaching Hospital of Kigali and Muhima Hospital which is the largest maternity hospital in Kigali, Rwanda. At admission, ultrasound was performed and documented the presence of ascites. Patients were stratified by the presence of ascites in perinatal period. Serial ultrasound was performed in antepartum and postpartum period. Maternal demographics and maternal and neonatal complications were recorded and compared between groups. Results: There were 112 patients in our cohort. Ascites was found in 53.5% of the cohort in peripartum period, 76.7% in antepartum, 23.3% in postpartum. The ascites group delivered at an earlier gestational age (32.2 ± 0.51 wks vs 33.8 ± 0.56wks. p=0.022). The birthweight was also significantly decreased in the ascites group (1587.3 ± 7703 gm vs. 2011.6 ±103 gm, p=0.002). There were lower Apgars in the ascites group (6.3 ± 0.45 vs. 7.7 ± 0.32, p=0.015). Maternal hospital stay was increased in the ascites group at 7.76 ± 0.52 days vs 5.4 ± 0.39, p<0.0001. Conclusions: Ascites is common in severe pre-eclampsia in Rwanda and is present in more than 50% of our cohort and may be a prognosticator for poor outcomes. A larger sample is necessary to determine whether it is independently associated with maternal morbidity and mortality and whether documenting the presence of ascites will help in planning the management of the fetus and mother.
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